Evidence map›Paper›PMID 23296314›Full record

ArticlePhysics in medicine and biology2013

Single-scan dual-tracer FLT+FDG PET tumor characterization.

Dan J Kadrmas, Thomas C Rust, John M Hoffman

Abstract read
In one paragraph

Article in Physics in medicine and biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Dual-Tracer Imaging on a Long-Axial-Field-of-View PET: A Proof-of-Principle Study with [Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  3. Multiplexed imaging of radionuclides.Nature biomedical engineering · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. AI for PET image reconstruction.The British journal of radiology · 2023
    Review
  8. Article
  9. Multiplexed imaging in oncology.Nature biomedical engineering · 2022
    Review
  10. Principles of Tracer Kinetic Analysis in Oncology, Part II: Examples and Future Directions.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  11. Simultaneous radiomethylation of [Scientific reports · 2022
    Article
  12. Transpathology: molecular imaging-based pathology.European journal of nuclear medicine and molecular imaging · 2021
    Review
  13. Article
  14. PET Parametric Imaging: Past, Present, and Future.IEEE transactions on radiation and plasma medical sciences · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. (18)F-alfatide II and (18)F-FDG dual-tracer dynamic PET for parametric, early prediction of tumor response to therapy.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2014
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dan J KadrmasUtah Center for Advanced Imaging Research, University of Utah, Salt Lake City, UT, USA. kadrmas@ucair.med.utah.edu
Thomas C Rust
John M Hoffman

Funding

UTAH REGIONAL CANCER CENTERP30CA042014 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Jared P Rutter · 1986 to 2026
$72.6M
Multi-Tracer PET Tumor ImagingR01CA135556 · NCI · UNIVERSITY OF UTAH · PI KADRMAS, DAN J · 2009 to 2017
$2.8M
NCI NIH HHS 3P30CA042014NCI NIH HHS P30 CA042014NCI NIH HHS R01 CA135556NCI NIH HHS R01CA135556
6 · The paper itself

Abstract

Rapid multi-tracer PET aims to image two or more tracers in a single scan, simultaneously characterizing multiple aspects of physiology and function without the need for repeat imaging visits. Using dynamic imaging with staggered injections, constraints on the kinetic behavior of each tracer are applied to recover individual-tracer measures from the multi-tracer PET signal. The ability to rapidly and reliably image both (18)F-fluorodeoxyglucose (FDG) and (18)F-fluorothymidine (FLT) would provide complementary measures of tumor metabolism and proliferative activity, with important applications in guiding oncologic treatment decisions and assessing response. However, this tracer combination presents one of the most challenging dual-tracer signal-separation problems--both tracers have the same radioactive half-life, and the injection delay is short relative to the half-life and tracer kinetics. This work investigates techniques for single-scan dual-tracer FLT+FDG PET tumor imaging, characterizing the performance of recovering static and dynamic imaging measures for each tracer from dual-tracer datasets. Simulation studies were performed to characterize dual-tracer signal-separation performance for imaging protocols with both injection orders and injection delays of 10-60 min. Better performance was observed when FLT was administered first, and longer delays before administration of FDG provided more robust signal-separation and recovery of the single-tracer imaging measures. An injection delay of 30 min led to good recovery (R > 0.96) of static image values (e.g. SUV), K(net), and K(1) as compared to values from separate, single-tracer time-activity curves. Recovery of higher order rate parameters (k(2), k(3)) was less robust, indicating that information regarding these parameters was harder to recover in the presence of statistical noise and dual-tracer effects. Performance of the dual-tracer FLT(0 min)+FDG(32 min) technique was further evaluated using PET/CT imaging studies in five patients with primary brain tumors where the data from separate scans of each tracer were combined to synthesize dual-tracer scans with known single-tracer components; results demonstrated similar dual-tracer signal recovery performance. We conclude that rapid dual-tracer FLT+FDG tumor imaging is feasible and can provide quantitative tumor imaging measures comparable to those from conventional separate-scan imaging.

Indexed as

DideoxynucleosidesFluorodeoxyglucose F18Brain NeoplasmsClinical Trials as TopicFeasibility StudiesHumansImage Processing, Computer-AssistedInjectionsPositron-Emission TomographyTime FactorsalovudineDideoxynucleosidesFluorodeoxyglucose F18

Identifiers

PMID23296314
PMCPMC3553659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.